Abiomed

ABMD
Real-time BATS EXCHANGE - 07/23 01:49:46 pm
263.21USD
-0.24%
Prev.263.9700
Open265.2600
High266.6600
Low261.2900
Volume219 572
Financials
Sales 2020 928 M
EBIT 2020 278 M
Net income 2020 208 M
Finance 2020 790 M
Yield 2020 -
P/E ratio 2020 58,7x
P/E ratio 2021 45,8x
EV / Sales2020 12,0x
EV / Sales2021 9,44x
Capitalization 11 953 M
Company
Abiomed specializes in the development, manufacture and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows:
- product sales (96.1%): heart pumps (Impella brand);
- service provision (3.8%): including preventive...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2019-08-01 Earnings Release
Trading Rating :
Investor Rating :
Latest news
07/11ABIOMED : First Quarter Fiscal 2020 Earnings and Conference Call Notification
BU
06/14ABIOMED : Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women's Health
AQ
06/13ABIOMED : Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women's Health
BU
06/03ABIOMED INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
05/29ABIOMED : to Present at Upcoming Investor Conferences
BU
05/23ABIOMED : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
05/22ABIOMED : FDA Confirms Impella RP is Safe and Effective Only Right-Sided Device with FDA Approval
AQ
05/22ABIOMED : National Cardiogenic Shock Initiative with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBearishBearish
Resistance272302333
Spread/Res.-3,4%-13%-21%
Spread/Supp.4,8%4,8%4,8%
Support251251251